Harvard Medical School Researchers To Build Next Generation Discovery And Diagnostics Methods With Lumera Corporation’s ProteomicProcessor(TM) Biosensor

BOTHELL, Wash.--(BUSINESS WIRE)--Lumera Corporation (Nasdaq:LMRA), an emerging leader in the field of nanotechnology, announced that Harvard Medical School researchers are now building next generation discovery and diagnostics methods with Lumera’s ProteomicProcessor™ Biosensor.